1. Home
  2. ITT vs GH Comparison

ITT vs GH Comparison

Compare ITT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ITT Inc.

ITT

ITT Inc.

HOLD

Current Price

$174.11

Market Cap

14.4B

Sector

Industrials

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$103.73

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITT
GH
Founded
1920
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
14.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ITT
GH
Price
$174.11
$103.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
21
Target Price
$203.89
$82.76
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
10-29-2025
10-29-2025
Dividend Yield
0.81%
N/A
EPS Growth
2.16
N/A
EPS
5.99
N/A
Revenue
$3,813,500,000.00
$902,569,000.00
Revenue This Year
$7.91
$34.72
Revenue Next Year
$5.90
$26.46
P/E Ratio
$29.01
N/A
Revenue Growth
8.01
30.38
52 Week Low
$105.64
$29.91
52 Week High
$197.07
$112.43

Technical Indicators

Market Signals
Indicator
ITT
GH
Relative Strength Index (RSI) 42.34 58.38
Support Level $170.45 $100.21
Resistance Level $176.49 $109.59
Average True Range (ATR) 5.00 3.88
MACD -0.92 -1.50
Stochastic Oscillator 37.72 29.47

Price Performance

Historical Comparison
ITT
GH

About ITT ITT Inc.

ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: